Meta-analysis finds no clinically significant outcome differences with postoperative glenoid retroversion ≥15° after aTSA
This systematic review and meta-analysis examined the association between postoperative glenoid component retroversion and clinical outcomes following primary anatomic total shoulder arthroplasty (aTSA). The analysis pooled data from 15 studies encompassing 1,190 shoulders, comparing outcomes between patients with postoperative glenoid retroversion <15° and those with retroversion ≥15°. The primary outcome was patient-reported clinical outcomes, with secondary outcomes including range of motion and complications.
The main finding was that no clinically significant differences were noted in patient-reported outcome scores, range of motion, or complications between the two retroversion groups. The analysis did not report specific effect sizes, absolute numbers, or statistical confidence intervals for these comparisons. The study setting and follow-up duration were not reported in the available data.
Safety and tolerability data, including adverse events and discontinuations, were not reported. A key limitation acknowledged by the authors is the need for future studies with long-term follow-up to assess the durability of these findings over time. The review's practice relevance is restrained, indicating it did not find evidence that postoperative glenoid component retroversion of <15° or ≥15° was associated with clinically significant differences in patient outcomes in the studied timeframe.